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reference should be inserted:
[170]. Sorrentino, G. and Bonavita, V. (2007) Neurodegeneration
and Alzheimer’s disease: the lesson from tauopathies. Neurol. Sci.
28, 63–71.
The ﬁrst 19 lines of paragraph 4.2, on page 645, should read:
‘‘APP seems to have a role in neural degeneration mostly as it is
processed, rather than through Ab formation [15]. For instance,
there is now broad evidence of the neuroprotective and neuropro-
liferative role of sAPPa in adult neuron [92,93]. Moreover, mice
lacking APP show a smaller brain size [94], and sAPPa expression
alone reverses this effect [95]. Furthermore, it has been showed
that ERK-induced axon growth is prompted by sAPPa and sAPPb
(generated in a 9:1 ratio) and that amino terminal fragments of
APP can shift stem cell growth toward a neural phenotype [96].
Overall, all this evidence seems to suggest that APP processing
might be an important inductor of neural stem cell differentiation
[15] (Fig. 2).’’Lines 19–42, on page 646, paragraph 6.0, should read:
‘‘The association between AD and ApoE is documented by
observations of structural variants of the ApoE protein [133]. In
humans, ApoE4 expression increases as a consequence of neuronal
damage and a neuron-speciﬁc proteolysis, guided by astrocytes,
takes place [151,152]. More speciﬁcally, ApoE4, cut by ApoE Cleav-
ing Enzyme (AECE) and missing the 272–299 residues (D272–299),
is not processed by the secretory pathway as it translocates to the
cytosol [133]. On the other hand, D272–299-ApoE4 is integrated in
the neuroﬁbrillary tangle-like structures [152]. Accordingly, mice
overexpressing cleaved-ApoE4 die within 4 months as they form
AD-like neuroﬁbrillary tangles. Furthermore, when mutated ApoE
is expressed at lower levels, learning and memory deﬁcits are
observed at 6–7 months [153]. In addition, in Neuro-2a cell line,
the D272–299-ApoE4 impairs complex III and IV respiratory func-
tions [154], and mice expressing the same variant of ApoE display
impaired axonal transport, with mitochondria accumulation in
bulb-like dilations [133,155].’’
